Waycross Partners LLC Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Key Points

• Waycross Partners LLC increased its stake in Intuitive Surgical by 22.7%, holding 50,220 shares valued at approximately $24.87 million.
• Intuitive Surgical reported a 21.4% increase in revenue year-over-year, with EPS of $2.19 exceeding estimates of $1.93.
• Analysts maintain a consensus "Moderate Buy" rating for the stock, with a price target averaging $595.95 per share.

Waycross Partners LLC lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 22.7% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 50,220 shares of the medical equipment provider's stock after purchasing an additional 9,277 shares during the period. Intuitive Surgical comprises approximately 2.8% of Waycross Partners LLC's holdings, making the stock its 15th biggest position. Waycross Partners LLC's holdings in Intuitive Surgical were worth $24,872,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. GAMMA Investing LLC lifted its stake in shares of Intuitive Surgical by 54,010.7% in the 1st quarter. GAMMA Investing LLC now owns 3,028,576 shares of the medical equipment provider's stock worth $14,999,630,000 after purchasing an additional 3,022,979 shares during the period. Capital Research Global Investors lifted its stake in shares of Intuitive Surgical by 25.5% in the 4th quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider's stock worth $1,764,904,000 after purchasing an additional 687,906 shares during the period. Goldman Sachs Group Inc. lifted its stake in shares of Intuitive Surgical by 26.1% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,819,666 shares of the medical equipment provider's stock worth $1,396,496,000 after purchasing an additional 584,375 shares during the period. Northern Trust Corp increased its holdings in Intuitive Surgical by 15.8% in the 4th quarter. Northern Trust Corp now owns 3,619,293 shares of the medical equipment provider's stock worth $1,889,126,000 after acquiring an additional 494,496 shares in the last quarter. Finally, Vanguard Group Inc. increased its holdings in Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider's stock worth $16,178,258,000 after acquiring an additional 453,335 shares in the last quarter. Institutional investors own 83.64% of the company's stock.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of Intuitive Surgical stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the sale, the senior vice president directly owned 907 shares in the company, valued at $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Gary S. Guthart sold 2,800 shares of Intuitive Surgical stock in a transaction dated Monday, July 28th. The shares were sold at an average price of $495.24, for a total value of $1,386,672.00. Following the completion of the transaction, the insider owned 18,520 shares in the company, valued at $9,171,844.80. This trade represents a 13.13% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 15,903 shares of company stock worth $7,932,778. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded up $0.27 on Friday, hitting $470.08. 1,445,546 shares of the stock were exchanged, compared to its average volume of 2,319,941. The stock has a fifty day moving average price of $516.52 and a two-hundred day moving average price of $529.35. The firm has a market capitalization of $168.51 billion, a P/E ratio of 65.56, a P/E/G ratio of 4.92 and a beta of 1.59. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%. The business had revenue of $2.44 billion during the quarter, compared to the consensus estimate of $2.35 billion. During the same period last year, the company earned $1.78 earnings per share. The business's revenue for the quarter was up 21.4% compared to the same quarter last year. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. Royal Bank Of Canada increased their target price on shares of Intuitive Surgical from $605.00 to $615.00 and gave the stock an "outperform" rating in a report on Wednesday, July 23rd. Barclays reduced their target price on shares of Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a report on Thursday, April 24th. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Saturday, July 26th. Truist Financial increased their target price on shares of Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Finally, Evercore ISI increased their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $595.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.